Early bird registration is open and closes May 2025. Register now
Abstracts deadline EXTENDED Friday 22 May 2026! Submit now
Latest Evidence on Methotrexate and JAK Inhibitors Objectives: This session will discuss the combination therapy of JAK inhibitors with MTX and JAK inhibitors monotherapy. Agenda – Saturday 31 October Chairperson: Seong-Ho Kim 1730-1825 Latest Evidence on Methotrexate and JAK Inhibitors Yuko Kaneko
Objectives: Speaker will give comprehensive lecture for PMR patient management Disease characteristics and burden Diagnosis &Treatment guidelines and recommendations Unmet needs in PMR management Deliver biologics treatment value with urgency and important of symptom control for patient long-term life Agenda – Saturday 31 October Chairperson: Chan-Bum Choi 1300-1305 Opening Chan-Bum Choi 1305-1355 Polymyalgia Rheumatica: From Diagnosis to Long-Term Disease Control – Current Recommendations and Unmet Needs Frank Buttgereit 1355-1415 Q&A Chan-Bum Choi 1415-1420 Closing remarks Chan-Bum Choi
Speakers:Xenofon Baraliakos Agenda – Friday 30 October Chairperson: Taehwan Kim TBC Presentation title TBC Xenofon Baraliakos
Belimumab: 15 Years of Changing the Lupus Treatment Paradigm Session information coming soon. Agenda – Friday 30 October Workshop chairperson: TBC Presentation title TBC Yoshiya Tanaka TBC Presentation title TBC Hiroaki Niiro
Title TBC Information coming soon Agenda – Saturday 31 October Chairperson: Seung-Ki Kwok TBC Presentation title TBC Kunihiro Yamaoka
From Inflammation to Impact: Early Treatment Strategies in Spondyloarthritis Agenda – Saturday 31 October Chairperson: Kichul Shin TBC Presentation title TBC Masato Okada TBC Presentation title TBC Paul Bird
Objectives: Information coming soon. Agenda – Wednesday 30 October Workshop chairperson: Jose Paulo Lorenzo and E.I. Alekseeva TBC Presentation title TBC Zagrebneva Alena Igorevna TBC Presentation title TBC Alekseeva Ekaterina Ignatyevna TBC Presentation title TBC Serdal Uğurlu
Have you submitted your abstract yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.
